Trademarkia Logo

Canada

C$
Trademark Search in Canada
MULTIBODY

View On IC.GC.CA

MULTIBODY
REGISTERED

on 22 Jul 2019

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

CRESCENDO BIOLOGICS LIMITED

MeditrinaBabraham Research CampusCambridgeCB22 3AT

GB

Serial Number

1805601 filed on 20th Oct 2016

Registration Number

TMA1043483 registered on 22nd Jul 2019

Registration expiry Date

22nd Jul 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

MULTIBODY

Trademark usage description

biochemicals in the form of proteins for laboratory research purposes; antibodies and antibody fragments for scientific and laboratory use; monoclonal Read More

Classification Information

Class [001]
Biochemicals in the form of proteins for laboratory research purposes; antibodies and antibody fragments for scientific and laboratory use; monoclonal antibodies and antibody fragments for scientific and laboratory use; antibodies and antibody fragments for scientific research purposes; antibody reagents for scientific and laboratory use; antibodies and antibody fragments for use in the discovery, preclinical and clinical development of therapeutic products

Classification kind code

10

Class [005]
Pharmaceutical, veterinary, and therapeutic preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, namely anti-inflammatory preparations, allergies and allergic conditions, hypersensitivity reactions namely asthma, Churg-Strauss Syndrome, anaphylaxis, pneumonitis, arthus reaction, celiac disease, infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, organ and tissue transplant rejection, cardiovascular diseases, neurological disorders namely Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, degenerative disorders namely Parkinson's disease, Huntington's disease, multiple sclerosis, metabolic disorders namely bulimia nervosa, anorexia, obesity and hypothyroidism and dermatological diseases namely Bowen's disease, basal cell carcinoma, extra-mammary Paget's disease, erthropoietic protoporphyria, melanoma, squamous cell carcinoma, monoclonal antibodies for medical use; antibody fragments for medical therapies; monoclonal antibody therapies; antibodies and antibody fragments for medical and veterinary diagnostics; antibodies and antibody fragments for use in the discovery, preclinical and clinical development of therapeutic products; antibodies and antibody fragments for use in the manufacture of therapeutic products

Classification kind code

10

Class [040]
Treatment and transformation of materials, namely the manufacture of chemicals and biologicals for the pharmaceutical industry, antibodies and antibody fragments; services for the custom manufacture of therapies using antibodies and antibody fragments

Classification kind code

10

Class [042]
Scientific and technological services and research and design in the field of antibodies and antibody fragments; laboratory services relating to antibodies and antibody fragments; research into the development of antibodies and antibody fragments; provision of antibodies and antibody fragments for medical and veterinary purposes; engineering of antibodies and antibody fragments; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; consultancy services relating to the discovery, preclinical and clinical development of antibodies and antibody fragments for therapeutic products

Classification kind code

10

Mark Details

Serial Number

1805601

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 27th Jun 2019		Registration Pending
Submitted for opposition 42
on 3rd Apr 2019		Advertised
Submitted for opposition 26
on 14th Mar 2019		Approved
Submitted for opposition 27
on 21st Jan 2019		Approval Notice Sent
Submitted for opposition 15
on 12th Jun 2018		Correspondence Created
Submitted for opposition 22
on 20th Oct 2017		Search Recorded
Submitted for opposition 20
on 20th Oct 2017		Examiner's First Report
Submitted for opposition 31
on 24th Oct 2016		Formalized
Submitted for opposition 1
on 21st Oct 2016		Created
Submitted for opposition 30
on 20th Oct 2016		Filed